Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma

Tumor and non-tumor biopsies during radiofrequency ablation for hepatocellular carcinoma are both safe and feasible, with a low complication rate and no procedure-related deaths. We demonstrated the diagnostic utility of biopsies, revealing discrepancies in 5% of cases between tumor board and histological results, which could refine patient management strategies. We identified significant associations between hepatocellular carcinoma subtypes and recurrence rates, and found that molecular analysis based on frozen tumor samples is feasible in most cases and could be guided by the percentage of tumors cells on paraffin-embedded samples.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2025-04-22
DOI
https://doi.org/10.1016/j.jhepr.2025.101430
Citations
2
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
2.64
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma

Olivier Sutter, Marianne Ziol, Jean‐Charles Nault, G. Nkontchou et al.
2 citations
JHEP Reports
Hepatocellular Carcinoma Treatment and Prognosis
2.64
article

Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma

Olivier Sutter, Marianne Ziol, Jean‐Charles Nault, G. Nkontchou, Alix Demory, Lorraine Blaise, Lucie Del Pozo, Claudia Campani, Olivier Séror, Jessica Zucman‐Rossi, Pierre Nahon, Elvire Desjonqueres, Nathalie Ganne‐Carrié, Lorenzo Pescatori, Nathalie Barget, Carina Boros, Véronique Grando
article en
2 citations

Abstract

Tumor and non-tumor biopsies during radiofrequency ablation for hepatocellular carcinoma are both safe and feasible, with a low complication rate and no procedure-related deaths. We demonstrated the diagnostic utility of biopsies, revealing discrepancies in 5% of cases between tumor board and histological results, which could refine patient management strategies. We identified significant associations between hepatocellular carcinoma subtypes and recurrence rates, and found that molecular analysis based on frozen tumor samples is feasible in most cases and could be guided by the percentage of tumors cells on paraffin-embedded samples.

JHEP ReportsVol. 7(9)
Inserm (FR), Sorbonne Université (FR), Université Sorbonne Paris Nord (FR), Centre de Recherche des Cordeliers (FR), Assistance Publique – Hôpitaux de Paris (FR), Association pour la Recherche en Physiologie de l’Environnement (FR), Hôpital Avicenne (FR), University of Florence (IT)
Good health and well-being
Openalex Percentile: Top 11%
Hepatocellular Carcinoma Treatment and Prognosis
2.64
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.